Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001209191-21-026746

Options or other derivatives

  • Chief Executive Officer acquired 172,420 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Adcock Richard Chief Executive Officer 2021-03-09 Other acquisition · Restricted Stock Units +172,420 172,420 D
Loading xslF345X03/doc4.xml…